Story thread · 45 reports / 38 sources
STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs
statnews.com · 13d
How the coverage leans
Across 38 sources · syndicated copies counted once
Analysts say private deals involve drugmakers agreeing to lower prices in Medicaid, where prices are low, in return for no price cuts in Medicare.
First report: STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more — statnews.com, 14d
The coverage
- Sun Pharma agrees to Trump demand with zero pain
economictimes.indiatimes.com · 13d
- Three takeaways from Trump's latest drug pricing event
endpts.com · 13d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.